Integrative Therapy in Alcoholism

Summary

The main aim of this project consists in the investigation of the interaction of behavior therapy and Acamprosate in the outpatient treatment of alcoholic patients in a randomized, prospective and (regarding study medication Acamprosate vs. Placebo) double blind design. A total of 371 patients has been randomly assigned immediately after detoxification to one of three different outpatient treat-ment conditions.

Conditions

• Alcoholism

Interventions

DRUG

Acamprosate

Acamprosate

BEHAVIORAL

Integrative behavior therapy

Integrative behavior therapy

DRUG

Placebo

Placebo

Sponsors & Collaborators

• German Federal Ministry of Education and Research

  collaborator OTHER_GOV

• German Addiction Research Network

  collaborator OTHER

• Merck Sharp & Dohme LLC

  collaborator INDUSTRY

• University of Bonn

  collaborator OTHER

• Universität Duisburg-Essen

  collaborator OTHER

• University of Homburg

  collaborator OTHER

• Psychosomatic Clinic of Bergisch Gladbach

  collaborator UNKNOWN

• Heinrich-Heine University, Duesseldorf

  lead OTHER

Principal Investigators

• Wolfgang Gaebel, Professor · Department of Psychiatry and Psychotherapy, University of Düsseldorf

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

QUADRUPLE

Model

PARALLEL

Eligibility

Min Age

25 Years

Max Age

60 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2003-05-31

Completion

2006-12-31

Countries

• Germany

Study Locations